Skip to main content

Post-IPO Debt Biotechnology Companies

Explore 90 biotechnology startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
90
Total Funding
$12.2B
Avg Funding
$486.7M
Cities
21

Export 90 Post-IPO Debt Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Malvern, United States
$115.0M
raised

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico
$22.5M
raised

Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$600.0M
raised

Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Calgary, Canada
$361K
raised

Marvel Biosciences is a life sciences company.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Newton, United States
$6.0M
raised

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Farmington Hills, United States
$35.0M
raised

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ørsta, Norway
$1.5M
raised

Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$2.0M
raised

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Calabasas, United States
$7.0M
raised

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$75.0M
raised

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mölndal, Sweden
$9.2M
raised

Cinclus Pharma is a research based biotech company.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Richmond, United States
$450.0M
raised

Indivior is a specialty pharmaceuticals business.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$550.0M
raised

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$10.0M
raised

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$100.0M
raised

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
North Chicago, United States
$8.0B
raised

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.

Feb 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$100.0M
raised

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Feb 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$1.2M
raised

Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.

Jan 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New York, United States
$1.5M
raised

Cell Source focuses on developing cell therapy treatments based on the management of immune tolerance.

Jan 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Fort Collins, United States
$7.1M
raised

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Parsippany, United States
$1.8B
raised

Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$200.0M
raised

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

Dec 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$37.0M
raised

Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Chicago, United States
$26.0M
raised

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Malvern, United States
$60.0M
raised

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 90 companies

Ready to Connect with Post-IPO Debt Biotechnology Startups?

Get verified founder emails, funding details, and company data for 90 post-ipo debt biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked